Crescent Biopharma Inc (CBIO)

Finanzdaten der Crescent Biopharma Inc-Aktie (CBIO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00%-	1.04	-	-	-
	9.18%28.13	25.77	102.34	25.89	21.03
Research and Development	8.31%19.39	17.90	95.03	20.35	12.08
Operating Income/Loss	6.61%-26.36	-24.73	-91.49	-25.89	-21.03
Income Tax Expense/Benefit	-	-	2.00	-	-
	6.67%-24.84	-23.28	-92.40	-24.61	-21.79
Attributable To Parent	6.67%-24.84	-23.28	-92.40	-24.61	-21.79
Available To Common Stockholders, Basic	6.71%-22.69	-21.26	-81.06	-20.95	-19.00
Undistributed Earnings/Loss Allocated To Participating Securities, Basic	6.28%-2.15	-2.02	-11.34	-3.66	-2.79